EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Personalized Genotype‐Based Approach for Treatment of Phenylketonuria

Polina Gundorova iD, Behnam Yousefi, Mathias Woidy, Malcolm Summer Rose-Heine, Robin Khatri, Viviane Kasten, Stefan Bonn, Ania Carolina Muntau, Soeren Waldemar Gersting

Journal of Inherited Metabolic Disease · 2025

DOI: 10.1002/jimd.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2025. Verfasst von Polina Gundorova und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Children's Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Hauptthemen laut MEDLINE: Phenylketonurias, Phenylalanine Hydroxylase, Precision Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Academic Exchange Service, Alexander von Humboldt-Stiftung, BioMarin Pharmaceutical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extensive studies have examined the clinical manifestations, pathogenic mechanisms, and genetic variations of phenylketonuria (PKU) across different populations, resulting in a substantial collection of molecular genetic data on the phenylalanine hydroxylase ( PAH ) gene and its variants. However, many genotypes are associated with a range of clinical phenotypes, as well as variable responsiveness to sapropterin, presenting ongoing challenges for effective treatment. To address this, we enhanced the PAH activity landscapes method by incorporating high‐throughput techniques, including automated pipetting, integrated data processing via Gaussian modeling of 3D surfaces, and bioinformatics analyses with robust quality control. Using PAH activity landscapes, we visualized PAH enzymatic function across 99 common PAH genotypes under varying metabolic and therapeutic conditions. This deep functional phenotyping approach enabled us to identify distinct genotype subpopulations by using consensus clustering, correlate them with clinical phenotypes, and propose subpopulation‐specific treatment protocols. Our findings suggest that clinical phenotypes can be predicted and treatment regimens can be adjusted based on residual PAH function profiles. To further support personalized treatment strategies, we revised our publicly accessible PAH genotype & activity landscapes database to share the latest insights into PAH function and patient phenotypes—namely residual enzyme activity and responsiveness to sapropterin as conveyed by two alleles. This resource underscores the translational significance of functional research in PKU and offers a practical tool to support personalized treatment in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenylketonuriasPhenylalanine HydroxylasePrecision MedicineHumansGenotypePhenotypeBiopterins

Stichwörter der Autor:innen

misfoldingphenylalanine hydroxylasephenylketonuriasapropterin dihydrochloridetetrahydrobiopterin

Substanzen

Phenylalanine HydroxylasesapropterinBiopterins

Autor:innen und Institutionen

  • University Children's Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • German Center for Child and Adolescent Health (DZKJ), Partner Site Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Institute of Medical Systems Bioinformatics, Center for Biomedical AI (bAIome), Center for Molecular Neurobiology (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • University Children's Hospital, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

ORCID-Profile: Polina Gundorova

Förderung

  • German Academic Exchange Service
  • Alexander von Humboldt-Stiftung
  • BioMarin Pharmaceutical
  • Deutsche Forschungsgemeinschaft
  • Hamburg Macht Kinder Gesund foundation
  • Federal Ministry of Education and Research (BMBF), German Center for Child and Adolescent Health (DZKJ)

Zitieren

APA

Gundorova, P., Yousefi, B., Woidy, M., Rose-Heine, M. S., Khatri, R., Kasten, V., Bonn, S., Muntau, A. C., & Gersting, S. W. (2025). Personalized Genotype‐Based Approach for Treatment of Phenylketonuria. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.70067

Vancouver

Gundorova P, Yousefi B, Woidy M, Rose-Heine MS, Khatri R, Kasten V, et al. Personalized Genotype‐Based Approach for Treatment of Phenylketonuria. Journal of Inherited Metabolic Disease. 2025. doi:10.1002/jimd.70067

BibTeX
@article{Gundorova2025,
  author = {Gundorova, Polina and Yousefi, Behnam and Woidy, Mathias and Rose-Heine, Malcolm Summer and Khatri, Robin and Kasten, Viviane and Bonn, Stefan and Muntau, Ania Carolina and Gersting, Soeren Waldemar},
  title = {Personalized Genotype‐Based Approach for Treatment of Phenylketonuria},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2025},
  doi = {10.1002/jimd.70067}
}
Kostenlos starten →